Peptides UK

Research Peptides UK Melanotan II UK: Tanning Research, Melanocortin Science, Safety and UK Law Melanotan II is a synthetic cyclic peptide designed to imitate part of the body’s melanocortin signalling system. Early human experiments showed that it could increase skin pigmentation and trigger sexual effects, but the research programme never produced an authorised Melanotan II medicine. Online tanning, appetite and libido claims now extend far beyond the small and incomplete clinical evidence. Author: It’s Me & You Clinic Editorial TeamPublished: 21 July 2026Last reviewed: 21...

Research Peptides UK CJC-1295 No DAC + Ipamorelin Blend UK: What the Science Actually Supports CJC-1295 No DAC and Ipamorelin are frequently sold together as a dual peptide blend. The scientific rationale is that one component acts through the growth hormone-releasing hormone receptor and the other acts through the ghrelin receptor. That rationale is biologically credible, but direct human evidence for the exact co-formulated blend is absent from the published clinical record reviewed for this article. Author: It’s Me & You Clinic Editorial Team Published:...

Research Peptides UK Tesamorelin UK: What Human Research, Approved Use and UK Regulation Actually Show Tesamorelin is unusual in the peptide world because it is both a laboratory-designed growth hormone-releasing hormone analogue and the active ingredient in an authorised prescription medicine in the United States. That approval is narrow, indication-specific and does not extend to general weight loss, anti-ageing or physique enhancement. In the UK, no marketing authorisation was identified when this article was reviewed. Author: It’s Me & You Clinic Editorial Team Published: 20...

UK Peptides Research Guide Modified GRF 1-29 UK Explained: The Peptide Behind CJC No DAC Modified GRF 1-29 is a synthetic 29-amino-acid analogue of growth hormone-releasing hormone. It is commonly marketed as CJC-1295 without DAC, although the original scientific name CJC-1295 is more closely associated with a separate long-acting, albumin-binding compound. Written by: Editorial Research Team Published: 17 July 2026 Evidence checked: 17 July 2026 Regulatory sources checked: 17 July 2026 Reading time: Approximately 10 minutes Important: This guide explains peptide identity, published evidence, laboratory...